만성 치주염 환자의 치은 조직에서 RANK 및 RANKL의 발현

참고문헌 (37)

1. "Induction of the immune response to periodontopathic bacteria and its role in the pathogenesis of periodontitis", 14, pp.79~111 (1997)
2. "Role of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin in bone cell biology", 79, pp.243~253 (2001)
3. "Osteoclast differentiation factor is a ligand for osteoprotegerin", osteoclastogenesis- inhibitory factor and is identical to TRANCE, pp.1998, 95[DOI]
4. "Fibroblastic stromal cells express receptor activator of NF-kappa B ligand and support osteoclast differentiation", 15(8), pp.1459~1466 (2000)
5. "Involvement of T-lymphocytes in periodontal disease and in direct and indirect induction of bone resorptio", 12, pp.125~135 (2001)
6. "Expression of membrane-bound and soluble receptor activator of NF-kappaB ligand (RANKL) in human T cells", 94, pp.239~246 (2004)
7. "Regulatory mechanisms of osteoblast and osteoclast differentiation", 8, pp.147~159 (2002)
8. "RANKL-RANK signaling in osteoclastogenesis and bone disease", 12, pp.17~25 (2006)
9. "The roles of osteoprotegerin and osteoprotegerin ligand in the paracrine regulation of bone resorption", 15, pp.2~12 (2000)
10. "Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand", 96, pp.3540~3545 (1999)
11. "Identity of osteoclastogenesis inhibitory factor (OCIF) and osteoprotegerin (OPG): a mechanism by which OPG", OCIF inhibits osteoclastogenesis in vitro, 1998, pp.139, 1329~1337
12. "Protein kinase-A-dependent osteoprotegerin production on interleukin-1 stimulation in human gingival fibroblasts is distinct from periodontal ligament fibroblasts", 142, pp.490~497 (2005)
13. "Characterization of epithelial cells derived from periodontal ligament by gene expression patterns of bone-related and enamel proteins", 29, pp.111~117 (2005)
14. "Roles of receptor activator of nuclear factor-kappaB ligand (RANKL) and osteoprotegerin in periodontal health and disease", 43, pp.65~84 (2007)
15. "Expression of osteoprotegerin (osteoclastogenesis inhibitory factor) in cultures of human dental mesenchymal cells and epithelial cells", 14, pp.1486~1492 (1999)
16. "Functional human T-cell immunity and osteoprotegerin ligand control alveolar bone destruction in periodontal infection", 106, pp.R59~R67 (2000)
17. "In situ expression of RANKL, RANK, osteoprotegerin and cytokines in osteoclasts of rat periodontal tissue", 39, pp.42~49 (2004)
18. "Gingival sulcus bleeding a leading symptom in initial gingivitis", 15, pp.107~ (1971)
19. "Development of a classification system for periodontal diseases and conditions", 4, pp.1~6 (1999)
20. "MMP-2, MMP-8 Expression in gingival tissue of chronic periodontitis associated to Type 2 Diabetes Mellitus", 35, pp.661~674 (2005)
21. "Expression and activity of human Na+", I-symporterinhu- mangliomacellsbyadenovirus-mediatedgenedelivary, 2000, pp.7, 740~749
22. "Prostaglandin E2 is a main mediator in receptor activator of nuclear factor-kB ligand-dependent osteoclastogenesis induced by Porphyromonas gingivalis, Treponema denticola, and Treponema socranskii", 76, pp.813~820 (2005)
23. "Cytokine gene expression in chronic periodontitis", 28(9), pp.840~847 (2001)
24. "Gingival crevicular interleukin-1 and interleukin-1 receptor antagonist levels in periodontally healthy and diseased sites", 32, pp.524~529
25. "Receptor activator NF kappaB ligand (RANKL) and osteoprotegerin (OPG) protein expression in periodontitis", 38, pp.380~387 (2003)
26. "The molecular triad OPG", RANK, pp.2004, 15[DOI]
27. "LPS-stimulated human gingival fibroblasts inhibit the differentiation of monocytes into osteoclasts through the production of osteoprotegerin", 130, pp.338~344 (2002)
28. "Expression of RANKL and OPG mRNA in periodontal disease: possible involvement in bone destruction", 11, pp.17~21 (2003)
29. "Differential expression of RANKL and osteoprotegerin in gingival crevicular fluid of patients with periodontitis", 83, pp.166~169 (2004)
30. "Gingival crevicular fluid levels of RANKL and OPG in periodontal diseases: implications of their relative ratio", 34, pp.370~376 (2007)
31. "Differential expression of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA in periodontal diseases", 42, pp.287~293 (2007)
32. "Porphyromonas gingivalis induces receptor activator of NF-kappaB ligand expression in osteoblasts through the activator protein 1 pathway", 72, pp.1706~1714 (2004)
33. "Cytokine responses of human gingival fibroblasts to Actinobacillus actinomycetemcomitans cytolethal distending toxin", 30, pp.56~63 (2005)
34. "Gene expression of osteoclast differentiation factor is induced by lipopolysaccharide in mouse osteoblasts via Toll-like receptors", 166, pp.3574~3579 (2001)
35. "B and T lymphocytes are the primary sources of RANKL in the bone resorptive lesion of periodontal disease", 169, pp.987~998 (2006)
36. "PTH differentially regulates expression of RANKL and OPG", 19, pp.235~244 (2004)
37. "Osteoclast differentiation factor mediates an essential signal for bone resorption induced by 1 alpha, 25-dihydroxyvitamin D3, prostaglandin E2, or parathyroid hormone in the microenvironment of bone", 246, pp.337~341 (1998)